How can we leverage canine osteosarcoma to validate biomarkers and accelerate the pathway to new therapies? Integration of comparative biology, specifically the study of naturally occurring cancers in companion animals (primarily dogs) known as comparative oncology, over the last three decades has significantly transformed cancer research and translational medicine. The growth in amassed data gained […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!